Global Cardiac Point of Care Testing Kits Market – Industry Trends and Forecast to 2030

Global Cardiac Point of Care Testing Kits Market, By Product Type (Cardiac Markers Test, Analysers), End-User (Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Others), Prescription Mode (Prescription Based Testing, Over-The-Counter Testing), Distribution Channel (Direct Tenders, Retail) – Industry Trends and Forecast to 2030.

 Cardiac Point of Care Testing Kits Market Analysis and Size

Increasing government spending on the growth of healthcare infrastructure to facilitate advanced healthcare facilities is a critical factor escalating market growth, as is the increasing need to diagnose these diseases, the growing number of cardiac patients, changing lifestyle patterns, an increase in infectious diseases, and rapid economic development in emerging economies, among other factors driving the cardiac point of care testing. Furthermore, rising technological advancements and modernization in the healthcare sector will create new opportunities for the cardiac point of care testing kits market between 2023 and 2030.

Data Bridge Market Research analyses that the cardiac point of care testing kits market which was USD 1.50 billion in 2022, is expected to reach USD 3.22 billion by 2030, at a CAGR of 10.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cardiac Point of Care Testing Kits Market Scope and Segmentation  

Market Definition

Cardiac POC is a type of medical test used to diagnose patients. Cardiovascular POCs are blood tests that include cholesterol and coagulation testing. These include tests for brain natriuretic peptides and troponin. Troponins are used to investigate a variety of cardiovascular conditions such as coronary syndromes, heart failures, and acute myocardial infarction. Troponin, lactate, dehydrogenase isoenzymes, and brain natriuretic peptides are cardiac POCs that aid enzyme detection during critical cardiac conditions.

Cardiac Point of Care Testing Kits Market Dynamics

Drivers

• Enhance prevalence of chronic disorders 

The increasing number of disorders among the population as a result of changing modern lifestyles, dietary intake, obesity, and lack of exercise has resulted in an increase in the number of disorders and increased utilization of diagnostics kits, as well as increased efficiency of the diagnostic kits with increased test accuracy, drives the market of point care testing. Diabetes, oncology, cardiovascular disease, arthritis, respiratory disease, and many other chronic diseases Improved research and development with new technologies integrated in the medical sector, as well as the supply of needs required for curing patients' health with quick relief and results, all help to drive the market of cardiac point of care testing kits.

• Developing infrastructure and health care facilities

Increased market demand for medical diagnostic kits, with increased technology and techniques for performing procedures in the laboratory or at home, as well as ease of access to medical devices for detecting the problem. Improved hospital health facilities with newly developed technologies, as well as improved research and technology with new launches by key market players, help to accelerate market growth.

Opportunities

• Emerging underdeveloped regions with new developments and rising disorder 

Rapid acceptance of newly developed technologies in medical diagnostics for and enhancement testing with improved point-of-care testing with increased efficiency and accuracy of the test. Development of point-of-care testing across various regions, combined with increased demand for testing kits, drives the market to a greater extent, with increased market share during the forecast period.

Restraints/Challenges

• The rising cost of the point care testing medical devices 

The rapid advancement of technologies in the market, as well as increased production and manufacturing of medical devices used in hospitals for the detection of various disorders with increased efficiency and accuracy of the testing kit, resulted in an increase in the cost of testing procedures with newly developed testing kits. Increased cost of medical diagnostic devices may pose a challenge to the market's ability to grow at a higher value.

This cardiac point of care testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac point of care testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cardiac Point of Care Testing Kits Market Scope

The cardiac point of care testing kits market is segmented on the basis of product type, end-user, prescription mode and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Cardiac Markers Test
• Cardiac troponin (cTn) test
•  Myoglobin test
•  Creatine kinase MB isoenzyme (CK-MB) test
•  Combinational test kits
•  Brain natriuretic peptide (BNP) test
• Analysers

 End-User

• Research Laboratories
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Others

Prescription Mode

• Prescription Based Testing
• Over-The-Counter Testing

 Distribution Channel

• Direct Tenders
• Retail

Cardiac Point of Care Testing Kits Market Regional Analysis/Insights

The cardiac point of care testing kits market is analyzed and market size insights and trends are provided by country, product type, end-user, prescription mode and distribution channel as referenced above.

The countries covered in the cardiac point of care testing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cardiac point of care testing kits market because of favourable reimbursement policies, well-developed healthcare infrastructure for advanced healthcare services, and the presence of major players operating in countries.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of rising government spending on healthcare and innovative product offerings by prominent players operating in this region's emerging economies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The cardiac point of care testing kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cardiac point of care testing kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cardiac point of care testing kits market. The data is available for historic period 2011-2021.

Competitive Landscape and Cardiac Point of Care Testing Kits Market Share Analysis

The cardiac point of care testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac point of care testing kits market.

Some of the major players operating in the cardiac point of care testing kits market are:

• Abbott (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• BD (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Danaher (U.S.)
• Sekisui Diagnostics (U.S.)
• Trinity Biotech (Ireland)
• BIOMÉRIEUX (France)
• EKF Diagnostics (Germany)
• AccuBioTech Co., Ltd. (China)
• Instrumentation Laboratory (U.S.)
• Beckman Coulter, Inc. (U.S.)
• PTS Diagnostics (U.S.)
• Nova Biomedical (U.S.)
• Chembio Diagnostics, Inc. (U.S.)
• Quidel Corporation (U.S.)
• Sienco, Inc (U.S.)

SKU-57145